Strength After Elbow Fractures in the Elderly
STAND-UP
Strength and Function After Non-operative Treatment of Displaced Olecranon Fractures in the Elderly: Implications of Standing UP From a Seat
1 other identifier
observational
50
1 country
1
Brief Summary
Elderly patients strength and function, specifically the ability to rise from a seat after either operative or non operative treatment of an mayo type 2 olecranon fracture.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 22, 2021
CompletedFirst Submitted
Initial submission to the registry
November 4, 2021
CompletedFirst Posted
Study publicly available on registry
November 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2027
February 27, 2025
February 1, 2025
5.9 years
November 4, 2021
February 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Extension Strength
Patients will push down on their distal forearm through a hand held dynamometer, to measure tricep extension strength
12 Months
Secondary Outcomes (4)
Arc of Motion
12 months
Mayo Elbow Performance Index
12 Months
Disabilities of the Arm, Shoulder, and Hand
12 Months
Satisfaction Score
6 weeks, 6 months and 12 months
Study Arms (2)
Operative
Internal fixation of the displaced olecranon fracture.
Non Operative
Conservative treatment as determined by the treating surgeon.
Interventions
Satisfaction, Disabilities of the Shoulder, Arm and Hand
Eligibility Criteria
Elderly patients for displaced olecranon fractures
You may qualify if:
- ≥65 years of age
- Mayo type II olecranon fracture
- Ambulatory (with or without the use of walking aides)
You may not qualify if:
- Additional injuries to the affected arm or contralateral arm
- Associated nerve injury
- Dementia or cognitive impairment that inhibits the collection of outcome measures
- Likely problems, in the judgement of the investigator, with maintaining follow-up (i.e. patients with no fixed address, not mentally competent to give consent, intellectually challenged, patients without adequate support, etc.)
- Injury or previous deficit to the contralateral arm
- Currently enrolled in any other research study involving drugs or medical devices
- Open fractures
- Inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Royal Columbian Hospital
New Westminster, British Columbia, V3L 3W7, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Farhad Moola, PhD
Orthopaedic Surgeon
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 4, 2021
First Posted
November 26, 2021
Study Start
February 22, 2021
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
July 1, 2027
Last Updated
February 27, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share